Summary (tl;dr)

The new post-apocalyptic horror film, "28 Years Later: The Bone Temple," directed by Nia DaCosta, is trending following its release in the UK and its impending US debut, garnering positive reviews from critics.

Essential Background

The "28 Days Later" franchise began in 2002 with Danny Boyle's critically acclaimed film, which revitalized the zombie horror genre with its portrayal of fast-moving infected individuals. A sequel, "28 Weeks Later," followed in 2007. The series was recently reignited with "28 Years Later," released in 2025, which laid the groundwork for the current installment.

The Full Story

"28 Years Later: The Bone Temple," the fourth film in the "28 Days Later" series, is currently trending due to its recent release. Directed by Nia DaCosta and written by Alex Garland, the movie premiered in the United Kingdom on January 13, 2026, and is scheduled for release in the United States on January 16, 2026. Filmed back-to-back with its predecessor, "28 Years Later" (2025), the film has received generally positive reviews from critics, who have praised DaCosta's direction and the performances of its cast, including Ralph Fiennes and Jack O'Connell. The plot continues the post-apocalyptic narrative, featuring a character named Dr. Kelson who has constructed an ossuary-monument, and a conflict with a "Clockwork-Orangey gang" led by Jimmy Crystal in a desolate England.

Why It Matters

The film's trending status reflects significant interest in the continuation of the popular "28 Days Later" saga, especially with Nia DaCosta, known for her work on "Candyman" and "The Marvels," taking on directorial duties for this installment. Its strong critical reception highlights its fresh take on the genre and its exploration of themes such as mortality, humanity, and faith amidst devastation. The simultaneous international release schedule is fueling widespread discussions among horror fans and film critics.

Geographic Location

• United Kingdom (film release)
• United States (scheduled film release)